Liquidia Corporation LQDA
Price alert —
Sign in to get a one-time email the moment LQDA crosses your price. Free accounts included.
Sign in / create a free accountLiquidia Corporation is a healthcare company listed in the US.
LQDA last traded at $89.03, up 2.3% on the day; that's in the upper part of its 52-week range ($29.12–$90.90). Right now it's stretched well above its recent average — moves this fast often cool off or give some back.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A quick snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 66), the trend is quiet (ADX 24), and volume is about normal (0.8×). On the business side, revenue is growing 4158% year over year and the business keeps about 6 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $6.38 (fair range $2–$7); today's price sits 1150% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ More cash than debt
- ✓ Quick ratio 2.04 (antifragile)
- ✓ Current ratio 2.01 (antifragile)
- ✓ Goodwill 1% of assets (organic growth)
- ⚠ Debt/equity 6.33 (fragile)
- ⚠ Negative retained earnings
- ⚠ Receivables growing faster than revenue
- ⚠ Inventory growing faster than revenue
Price implies ~77% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
LQDA is a $7.2 billion company, priced at 469× last year's earnings, and the stock is trading near the top of its 52-week range.